Changes in Beneficial Ownership · 4

Recursion Pharmaceuticals, Inc.

RXRXNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Oct 7, 2026Accepted Oct 7, 2026, 6:08 PM EDTFiling CIK 1601830Accession 0001601830-26-000119

wk-form4_1791410900.xml

Name: HERSHBERG ROBERT
Reporting owner CIK: 0001274139
Relationship: Director
Address: C/O RECURSION PHARMACEUTICALS, 41 S. RIO GRANDE STREET, SALT LAKE CITY, UT, 84101

Non-derivative transactions · 2 reported rows
Security	Transaction date	Code	Amount	A / D	Price (USD)	Owned after	Ownership
Class A Common Stock	2026-10-06	M · Form 4^[F1]	25,000	A	2.22	187,156	D
Class A Common Stock	2026-10-06	S · Form 4	25,000	D	5	162,156	D

Table key

Derivative transactions · 1 reported row
Security	Conversion / exercise price (USD)	Transaction date	Code	Amount	A / D	Price (USD)	Exercisable	Expires	Underlying security	Underlying shares	Owned after	Ownership
Stock Option (Right to Buy)	2.22	2026-10-06	M · Form 4	25,000	D	2.22	^[F2]	2030-03-19	Class A Common Stock	25,000	500,000	D

Table key

F1: This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025.↩ 1
F2: One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 16, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. Date exercisable varies by tranche.↩ 1